LuMind Research Down Syndrome Foundation relocates to Burlington, MA

Categories: Blog, Events, Media, News, Press
Boy Welcomes to Office
BURLINGTON, Ma—(October 22, 2018)—Local nonprofit organization, LuMind Research Down Syndrome Foundation (LuMind RDS), opened its new office at 20 Burlington Mall Road in Burlington, Massachusetts on October 15, 2018. The foundation, which focuses on results-driven Down syndrome research, is relocating from Marlborough, Massachusetts, where it has been headquartered the last 4 years. To celebrate, LuMind …

Read More

Ready for research: LuMind Research Down Syndrome Foundation gears up to host Funding Futures New York

Categories: Blog, News
Funding Futures Chicago
NEW YORK CITY—(September 5, 2018)—The inaugural Funding Futures New York Gala is set to take place on Thursday, September 20 at City Winery in New York City. The event, which originated in Chicago seven  years ago, aims to raise funds and awareness for Down syndrome research through LuMind Research Down Syndrome Foundation (LuMind RDS). LuMind …

Read More

Rockin’ Mom chooses Phoenix, AZ for its third annual Rockin’ It 5K to support families and individuals with Down syndrome

Categories: Blog, Media, News, Press
Glow Run
LuMind Research Down Syndrome Foundation™ and Down Syndrome Diagnosis Center™ join forces to raise awareness and funds PHOENIX – (August 14, 2018) – One of the largest retreats for mothers of children with Down syndrome – Rockin’ Mom Retreat – is coming to the JW Marriott Desert Ridge Resort and Spa in Phoenix, Arizona September …

Read More

McCordsville mom’s cornhole tournament benefits Down syndrome research

Categories: Blog, Media, News, Press
Mari Kennedy Son
   McCordsville mom’s cornhole tournament benefits Down syndrome research INDIANAPOLIS (July 31, 2018) – McCordsville, Indiana mother and Down syndrome advocate, Mari Kennedy, is helping accelerate breakthroughs in Down syndrome and Alzheimer’s disease research for her son, Ryan, with a few bags of corn. “I learned a few years ago that Down syndrome research received …

Read More

Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019

Categories: Blog, News, Other, Press
Official LuMind RDS Announcement Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche (Roche) trials that took place from 2011 to 2016 with their GABA-A targeting molecule basmisanil (RG1662) tested for improving cognition in people with Down syndrome. As you may know, Roche first conducted a small 35-person Phase …

Read More